ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,575.99
0.26%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) 뉴스

TEVA Teva Pharmaceutical Industries Ltd

13.89
0.64 (4.83%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Teva Pharmaceutical Industries Ltd TEVA NYSE 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.64 4.83% 13.89 09:00:00
개장가 저가 고가 종가 전일 종가
13.31 13.31 13.98 13.81 13.25
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202406:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
17/04/202406:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/04/202421:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
11/04/202421:30BWTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab)..
10/04/202405:30BWTeva to Host Conference Call to Discuss First Quarter 2024..
07/04/202402:00BWNew Pharmacokinetic Modeling Data Presented by Teva..
04/04/202421:30BWTeva and mAbxience Announce Strategic Global Licensing..
01/04/202421:30BWClinical Collaboration Agreement between Teva and Launch..
08/03/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/03/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202421:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
24/02/202410:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/02/202410:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
20/02/202422:30BWTeva Presents New Data Supporting Safety, Tolerability and..
13/02/202423:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
13/02/202407:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
12/02/202423:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
01/02/202421:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202421:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202421:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202421:00EDGAR2Form 8-K - Current report
31/01/202421:00BWTeva Reports Growth in Fourth Quarter and Full Year 2023
31/01/202420:00BWTeva Announces Intention to Divest API Business as Part of..
03/01/202406:30BWTeva to Host Conference Call to Discuss Fourth Quarter and..
02/01/202422:50DJNCorcept Therapeutics Shares Slide Premarket on Loss in Teva..
29/12/202306:30BWTeva to Present at the 42nd Annual J.P. Morgan Healthcare..
14/12/202322:30BWTeva and Biolojic Design Announce Exclusive License..

최근 히스토리

NYSE
TEVA
Teva Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유